Dihydropyridinone derivatives

US8097629B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Heike Gielen-Haertwig · Monheim, DE
• Barbara Albrecht · Wuppertal, DE
• Marcus Bauser · Berlin, DE
• Jörg Keldenich · Wuppertal, DE
• Volkhart Min-Jian Li · Velbert, DE
• Josef Pernerstorfer · Wuppertal, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Leila Telan · Wuppertal, DE

Key dates

• Filing date: Feb 5, 2005
• Grant date: Jan 17, 2012
• Expiry date: May 20, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D409/12
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to novel dihydropyridinone derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.